Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: Italy Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20062
20071
20081
20094
20106
20112
20132
20141
20161
20181
20211
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated4
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Sanofi3
Eli Lilly and Company2
Gennaro Sardella2
GlaxoSmithKline2
Anthera Pharmaceuticals1
Azienda Ospedaliera Universitaria Policlinico "G. Martino"1
Bristol-Myers Squibb1
CSL Behring1
Cogentus Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome27
Coronary Artery Disease7
Myocardial Infarction7
Non-ST Elevated Myocardial Infarction5
ST Elevation Myocardial Infarction5
Cardiovascular Diseases4
Heart Diseases4
Stroke3
Atherosclerosis2
Angina, Unstable1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.